Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Novus Therapeutics, Inc. (NASDAQ: NVUS).

Full DD Report for NVUS

You must become a subscriber to view this report.


Recent News from (NASDAQ: NVUS)

Midday Gainers / Losers (09/07/2018)
Gainers:  OKTA +20% . NVUS +17% . XENE +16% . NX +16% . DRNA +15% . ZEAL +15% . SHLO +15% . TIS +13% . FIVE +13% . MCFT +11% . More news on: Okta, Inc., Novus Therapeutics, Xenon Pharmaceuticals, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 07 2018 12:47
Novus Therapeutics to Postpone Offering of Common Stock
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”), today announced that it has elected to postpone the previously announced public offering of its common st...
Source: Business Wire
Date: September, 07 2018 09:25
Premarket Gainers as of 9:05 am (09/07/2018)
NVUS +37%  on regaining its 24% slide. More news on: Novus Therapeutics, Okta, Inc., Five Below, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 07 2018 09:23
Novus Therapeutics up 41% premarket
Thinly traded nano cap Novus Therapeutics (NASDAQ: NVUS ) is up  41%  premarket on increased volume, poised to regain the week's  24%  slide and then some. On Tuesday after the close, it announced a 6M-share stock offering although the price was not released. More news ...
Source: SeekingAlpha
Date: September, 07 2018 08:14

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-145.205.205.324.99134,051

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-104,7335,34688.5335Short
2018-12-071,9232,63473.0068Short
2018-12-061,2051,32091.2879Short
2018-12-041,0006,84414.6113Cover
2018-12-032,64512,74820.7484Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NVUS.


About Novus Therapeutics, Inc. (NASDAQ: NVUS)

Logo for Novus Therapeutics, Inc. (NASDAQ: NVUS)

Not available

 

Contact Information

     

     

    Current Share Structure

    • Market Cap: $15,396,304 - 05/18/2018
    • Issue and Outstanding: 2,515,736 - 05/11/2017

     


    Recent Filings from (NASDAQ: NVUS)

    Withdrawal of registration statement filed under the Securities Act
    Filing Type: RWFiling Source: edgar
    Filing Date: September, 07 2018
    Amendment to general form for registration of securities under the Securities Act of 1933
    Filing Type: S-1/AFiling Source: edgar
    Filing Date: September, 04 2018
    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: August, 07 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: August, 07 2018
    General form for registration of securities under the Securities Act of 1933
    Filing Type: S-1Filing Source: edgar
    Filing Date: August, 01 2018
    Notice from the SEC of registration effectiveness
    Filing Type: EFFECTFiling Source: edgar
    Filing Date: July, 31 2018
    Correspondence from the SEC to the Filer
    Filing Type: UPLOADFiling Source: edgar
    Filing Date: July, 31 2018
    Correspondence from the Filer to the SEC
    Filing Type: CORRESPFiling Source: edgar
    Filing Date: July, 30 2018
    Simplified registration form
    Filing Type: S-3Filing Source: edgar
    Filing Date: July, 23 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: June, 14 2018

     

     


    Daily Technical Chart for (NASDAQ: NVUS)

    Daily Technical Chart for (NASDAQ: NVUS)


    Stay tuned for daily updates and more on (NASDAQ: NVUS)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: NVUS)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NVUS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NVUS and does not buy, sell, or trade any shares of NVUS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/